blood-based cancer diagnostics

Cleveland Diagnostics, Inc. is a diagnostic innovator co-founded by the Cleveland Clinic that develops simple blood tests for early cancer detection. Its proprietary IsoClear platform measures structural differences in proteins to determine if biomarkers originated in cancer cells. Its first product, IsoPSA, is a laboratory developed test that clarifies in whom aggressive prostate cancer may reside and reduces unnecessary prostate biopsies.

Read more

laboratory developed testing (LDT)protein structural analysis